跳至主要内容
临床试验/NCT03180463
NCT03180463暂停1 期

The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC)

Sclnow Biotechnology Co., Ltd.1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年12月31日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
暂停
发起方
入组人数
30
试验地点
1
主要终点
MRI imageological examination

研究概览

简要总结

The purposes of the study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in treating osteonecrosis of femoral head patients.

详细描述

This is a randomized,double-blind, paralleled study. Patients will be divided into two groups of experiment and control. All of them will receive core decompression of the femoral head, while experimental group patient will transplant hUC-MSC in addition. Follow-up visit will occur on 1 month, 3 months, and 6 months after operation, and Harris Hip score was applied to evaluate the symptoms change.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

性别
All
接受健康志愿者

入选标准

  • Ficat classification is I, IIa, or IIb period
  • no obvious improvement or ingravescence by conservative treatment
  • patients or their statutory receive human umbilical cord mesenchymal stem cell of their own will, and signed informed consent form

排除标准

  • Ficat classification is third or fourth period
  • acute, chronic infection patients
  • combined with heart, lung, kidney disease, and cannot tolerate operation
  • ankylosing spondylitis patient
  • acetabular dysplasia patient
  • with tumor
  • clinical data deficient
  • HIV positive
  • pregnancy or breast feeding women
  • under other therapy that possibly influence MSC security or efficacy

研究组 & 干预措施

Group 1

Experimental

Core decompression surgery; Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#).

干预措施: Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#) (Drug)

Group 1

Experimental

Core decompression surgery; Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#).

干预措施: core decompression (Procedure)

Group 2

Placebo Comparator

Core decompression surgery.

干预措施: core decompression (Procedure)

结局指标

主要结局

MRI imageological examination

时间窗: 6 months

MRI imageological examination to evaluate the efficient of mesenchymal stem cells.

次要结局

  • Harris Hip Score(6 months)

研究者

发起方
Sclnow Biotechnology Co., Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验